AKBA vs AXP · rev $102.7M vs P/E 20, rev $21.73B
Akebia Ther (AKBA) versus American Express Company (AXP) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
American Express Company (AXP) is a credit services company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
AKBA currently screens at market cap $260.1M. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Not investment advice. Open the AKBA and AXP stock pages for the full models.
Not investment advice.